Brett Knoblauch

Jul 31, 2026

Brett Knoblauch rated DUOT as Overweight on Jul 31, 2026, setting a price target of 26. Shares have remained stable near 8.14, leaving the 26 target still in play.

Jul 30, 2026

On Jul 30, 2026, EQIX was given a Overweight rating by Brett Knoblauch, with a target price of 1211. The stock traded sideways with a 0.00% move, keeping the bullish thesis unresolved.

Jul 29, 2026

DLR received a Overweight rating from Brett Knoblauch on Jul 29, 2026, aiming for 221. Price action was muted, as shares hovered around 193.19 despite the bullish outlook.

Jul 15, 2026

On Jul 15, 2026, Brett Knoblauch published a Overweight outlook on WULF, with a target of 37. Market action contradicted the Buy thesis, as shares slipped to 17.82.

Jul 15, 2026

Brett Knoblauch on Jul 15, 2026 assigned CLSK a Overweight rating, with a price target of 26. The recommendation remains pending validation as shares consolidate around 14.54.

Jun 16, 2026

On Jun 16, 2026, Brett Knoblauch reaffirmed CRWV with a Overweight rating, targeting 167. Shares slid 36.85% despite the recommendation, highlighting downside risks.

May 28, 2026

IREN was rated Overweight by Brett Knoblauch on May 28, 2026, with a price objective of 99. This case shows how bullish projections can fail, with the stock now below 38.26.

May 19, 2026

On May 19, 2026, Brett Knoblauch initiated coverage on HIVE with a Overweight rating and target of 4.6. The Buy call has yet to be validated as shares remain 1.60 away from the target.

May 15, 2026

Brett Knoblauch issued a Overweight recommendation for BLSH on May 15, 2026, price target set at 43. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

May 14, 2026

On May 14, 2026, BTGO was given a Overweight rating by Brett Knoblauch, with a target price of 15. Despite the Buy call, shares fell from 5.05 to 5.05, challenging the optimistic stance.

May 13, 2026

FLD received a Overweight rating from Brett Knoblauch on May 13, 2026, aiming for 1.7. The rating hasn’t played out as hoped, with the stock trading 67.97% below expectations.

May 01, 2026

Brett Knoblauch on May 01, 2026 assigned RIOT a Overweight rating, with a price target of 23. The recommendation remains pending validation as shares consolidate around 22.12.

May 01, 2026

On May 01, 2026, Brett Knoblauch reaffirmed GLXY with a Overweight rating, targeting 30. Market indecision has kept the 30 target in a holding pattern.

Apr 09, 2026

NBIS was rated Overweight by Brett Knoblauch on Apr 09, 2026, with a price objective of 129. A bullish response from the market helped close the gap of -59.43 to the target.

Apr 09, 2026

On Apr 09, 2026, Brett Knoblauch initiated coverage on KEEL with a Overweight rating and target of 3. Neutral price movement of % leaves room for interpretation.

Apr 09, 2026

Brett Knoblauch issued a Overweight recommendation for MARA on Apr 09, 2026, price target set at 10. Investors following the Buy call captured upside momentum, with shares now at 11.82.

Apr 09, 2026

On Apr 09, 2026, HUT was evaluated by Brett Knoblauch, who gave a Overweight rating and target of 80. This case illustrates how a timely bullish rating can translate into tangible gains of 70.72%.

Apr 09, 2026

Brett Knoblauch rated CORZ as Overweight on Apr 09, 2026, setting a price target of 29. The call has proven timely, with shares rising 21.30% toward the price target of 29.

Apr 09, 2026

On Apr 09, 2026, CIFR was given a Overweight rating by Brett Knoblauch, with a target price of 22. The stock rallied 38.48% after the rating, narrowing the gap to the target of 22 and validating the bullish stance.

Apr 09, 2026

SHAZ received a Overweight rating from Brett Knoblauch on Apr 09, 2026, aiming for 40. Momentum has favored the Buy call, with shares climbing from 48.77 to 48.77, rewarding those who trusted the recommendation.

Mar 18, 2026

On Mar 18, 2026, Brett Knoblauch published a Market Outperform outlook on BCYC, with a target of 8. Market action contradicted the Buy thesis, as shares slipped to 4.01.

Feb 12, 2026

On Feb 12, 2026, Brett Knoblauch reaffirmed PURR with a Overweight rating, targeting 6. The recommendation was supported by strong follow-through as the stock rose from 6.3 to 6.3.

Feb 11, 2026

UPXI was rated Overweight by Brett Knoblauch on Feb 11, 2026, with a price objective of 6. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

Jan 12, 2026

On Jan 12, 2026, Brett Knoblauch initiated coverage on ETOR with a Overweight rating and target of 50. The stock’s climb of 13.08% since the call highlights the foresight in the rating.

Jan 05, 2026

Brett Knoblauch issued a Overweight recommendation for SBET on Jan 05, 2026, price target set at 15. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

Dec 18, 2025

On Dec 18, 2025, COIN was evaluated by Brett Knoblauch, who gave a Overweight rating and target of 459. So far, the Buy call awaits clearer momentum, with shares flat at 163.58.

Dec 16, 2025

Brett Knoblauch rated HYPD as Overweight on Dec 16, 2025, setting a price target of 4. The stock has underperformed, dropping 13.64% despite the bullish target of 4.

Dec 11, 2025

On Dec 11, 2025, HOOD was given a Overweight rating by Brett Knoblauch, with a target price of 155. Despite the Buy call, shares fell from 86.6 to 86.6, challenging the optimistic stance.

Nov 14, 2025

BITF received a Overweight rating from Brett Knoblauch on Nov 14, 2025, aiming for 5. The rating hasn’t played out as hoped, with the stock trading 16.28% below expectations.

Oct 31, 2025

On Oct 31, 2025, Brett Knoblauch published a Overweight outlook on MSTR, with a target of 560. Market action contradicted the Buy thesis, as shares slipped to 97.74.

Oct 21, 2025

Brett Knoblauch on Oct 21, 2025 assigned SUIG a Overweight rating, with a price target of 5. The call has struggled to gain traction, with shares losing 72.81%.

Aug 15, 2025

On Aug 15, 2025, Brett Knoblauch reaffirmed EVLV with a Overweight rating, targeting 9. Shares slid 29.29% despite the recommendation, highlighting downside risks.

Aug 15, 2025

EXOD was rated Overweight by Brett Knoblauch on Aug 15, 2025, with a price objective of 45. This case shows how bullish projections can fail, with the stock now below 5.34.

Aug 06, 2025

On Aug 06, 2025, Brett Knoblauch initiated coverage on SMLR with a Overweight rating and target of 60. The Buy call has yet to be validated as shares remain 39.67 away from the target.

Feb 20, 2025

Brett Knoblauch issued a Overweight recommendation for KVYO on Feb 20, 2025, price target set at 54. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

Feb 12, 2025

On Feb 12, 2025, FRSH was evaluated by Brett Knoblauch, who gave a Overweight rating and target of 22. Investors saw limited payoff as shares fell short of the 22 target.

Feb 06, 2025

Brett Knoblauch rated CSGS as Overweight on Feb 06, 2025, setting a price target of 72. The call has proven timely, with shares rising 24.02% toward the price target of 72.

Jan 15, 2025

On Jan 15, 2025, APLD was given a Overweight rating by Brett Knoblauch, with a target price of 14. The stock rallied 234.17% after the rating, narrowing the gap to the target of 14 and validating the bullish stance.

Aug 02, 2024

On Aug 02, 2024, Brett Knoblauch published a Overweight outlook on SPT, with a target of 46. Market action contradicted the Buy thesis, as shares slipped to 8.47.

Aug 01, 2024

Brett Knoblauch on Aug 01, 2024 assigned UDMY a Overweight rating, with a price target of 18. The call has struggled to gain traction, with shares losing 38.43%.

Jul 26, 2024

On Jul 26, 2024, Brett Knoblauch reaffirmed COUR with a Overweight rating, targeting 22. Shares slid 50.84% despite the recommendation, highlighting downside risks.

May 09, 2024

PWSC was rated Overweight by Brett Knoblauch on May 09, 2024, with a price objective of 25. A bullish response from the market helped close the gap of 2.19 to the target.

May 01, 2024

On May 01, 2024, Brett Knoblauch initiated coverage on FUBO with a Overweight rating and target of 2.9. The Buy call has yet to be validated as shares remain -5.69 away from the target.

Mar 08, 2024

On Mar 08, 2024, RBT was evaluated by Brett Knoblauch, who gave a Overweight rating and target of 1.6. Investors saw limited payoff as shares fell short of the 1.6 target.